|
|||||
|
|
Prior response to infliximab and early serum drug concentrations predict effects of adalimumab in ulcerative colitis |
|
| Authors: | F. Baert N. Vande Casteele S. Tops M. Noman G. Van Assche P. Rutgeerts A. Gils S. Vermeire M. Ferrante |
| Affiliation: | 1. Department of Gastroenterology, University Hospitals Leuven, , Leuven, Belgium;2. Department of Pharmaceutical and Pharmacological Sciences, Laboratory for Therapeutic and Diagnostic Antibodies, KU Leuven, , Leuven, Belgium |
| Abstract: | |
| Keywords: | |